As such, we are involved in the Marseille immunology biotope
I am the Director of Protisvalor, the research transfer subsidiary of Aix-Marseille University. Protisvalor was founded in 2002 to provide laboratories and researchers with the necessary assistance to valorize their expertise and the results of their research. Since then, we have actively supported the University’s teams in their innovation activities and collaborations with industry and ensure the administrative and financial management of strategic R&D platforms, such as the MI-mAbs pre-industrial demonstrator.
As such, we are involved in the Marseille immunology biotope, so it is natural that today we fully support this initiative.#ecosystem
Each year, a large number of clinical trials are conducted by APHM clinicians alone or in partnership with industry players in biopharmaceuticals.
AMU, AP-HM, CIML
Cell- and tissue- based therapies and gene therapies hold great promise in the field of both immunotherapy and regenerative medicine.
AMU, IPC, AP-HM, Inserm
A therapeutic revolution is happening.
CIML, Canceropôle PACA
Our aim is simple: to position ourselves upstream of the diagnosis and to propose innovative treatments to patients
AMU, IPC, CRCM